Pharmaceutics product development scientists are at the forefront of creating new pharmaceutical formulations that meet both therapeutic goals and patient needs. Their primary responsibility is to design drug products that deliver active pharmaceutical ingredients effectively and safely. This involves selecting the right combination of excipients, optimizing dosage forms, and improving drug stability and bioavailability. They use a variety of formulation techniques to develop products such as tablets, capsules, injectables, and novel delivery systems like transdermal patches or nanoparticle-based carriers. By conducting extensive preformulation and formulation studies, these scientists ensure the drug’s effectiveness while minimizing side effects and maximizing patient compliance.
Moreover, pharmaceutics product development scientists play a critical role in the entire product lifecycle, from initial concept to commercial production. They collaborate with analytical scientists, regulatory experts, and manufacturing teams to ensure that products meet quality standards and regulatory requirements. Their work often includes performing stability testing, compatibility studies, and scale-up processes to ensure that laboratory formulations can be produced consistently on an industrial scale. With ongoing advancements in drug delivery technologies and personalized medicine, these scientists continue to innovate, developing safer, more effective pharmaceutical products that address complex medical challenges and improve global health outcomes. Their contributions are essential to bringing new and improved therapies to patients worldwide.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand